Dupilumab for COPD tied to improvement in health-related …
WEB1 day ago · Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, according to a study presented at CHEST 2024, the ...
CHEST: Dupilumab for COPD Tied to Improvement in Health …
WEB1 day ago · By Lori Solomon HealthDay Reporter. MONDAY, Oct. 7, 2024 -- Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, according to a study presented at CHEST 2024, the annual meeting of the American College of Chest Physicians, held from Oct. 6 to 9 in Boston.
Mepolizumab Reduces Exacerbations in Patients With Severe …
WEB3 hours ago · Mepolizumab significantly reduces exacerbations in patients with asthma and concurrent chronic obstructive pulmonary disease (COPD), with a 55% reduction in COPD exacerbations post initiation.
FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease
WEB6 days ago · TUESDAY, Oct. 1, 2024 -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. The approval was based on results from two pivotal phase 3 trials (BOREAS and NOTUS) that ...
COPD News - ScienceDaily
WEB1 day ago · Latest research news on COPD, including chronic bronchitis, chronic obstructive airway disease, chronic obstructive lung disease and emphysema.
Smoking is the leading cause of chronic obstructive pulmonary disease
WEBNov 15, 2023 · A new brief reveals that smoking remains one of the leading causes of chronic obstructive pulmonary disease (COPD), a common lung disease that causes breathing problem and claiming the lives of over 3 million people every year.
2024 GOLD Report Reflects New Research on COPD Management
WEBDec 8, 2023 · The 2024 GOLD Report, “Global Strategy for Prevention Diagnosis and Management of COPD,” not only includes guideline updates that reflect the latest research on chronic obstructive pulmonary disease (COPD); it also reflects some shifts in thinking about what’s important in COPD treatment, according to Claus Vogelmeier, MD, a lead report author a...
Chronic obstructive pulmonary disease (COPD)
WEBMar 16, 2023 · WHO fact sheet on chronic obstructive pulmonary disease (COPD) provides key facts and information on symptoms, diagnosis and treatment, risk factors and WHO response.
Immune treatment tackles chronic obstructive pulmonary disease …
WEBAug 16, 2023 · Chronic obstructive pulmonary disease (COPD) is a common lung disease caused by tobacco smoke and other airborne pollutants, and it can be fatal. COPD exacerbations — defined as acute...
GOLD COPD report: 2023 update - The Lancet Respiratory Medicine
WEBOn Nov 14, 2022, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) published their 2023 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).